TipRanks on MSN
Polyrizon’s PL-14 shows strong pre-clinical allergen-blocking advantage over standard ...
Polyrizon Ltd. ( ($PLRZ) ) has shared an announcement. On January 5, 2026, Polyrizon Ltd. reported positive in-vitro pre-clinical results showing ...
12 小时on MSN
Do Man City need transfers as 'make or break' January starts with Dias, Gvardiol injuries ...
Manchester City lost a lead, a point, and maybe a lot more in a span of 41 minutes of Sunday, as star defenders Josko ...
Man City might think they "controlled" Sunday's draw with Chelsea, but dropped points is all that matters. Plus: Joan Garcia ...
Yeshivat Chovevei Torah, 3700 Henry Hudson Pkwy. E.
In New Jersey, arriving early at these Italian restaurants turns patience into a prize: prime seats, attentive service, and ...
Think about this: Baltimore’s defense allowed 23 points in the 2nd half to an offense that only scored six points in an ...
14 小时on MSN
HELUS Pharma Propels Therapeutic Innovation in Mental Health and Commences Trading on Nasdaq
BOSTON & TORONTO--(BUSINESS WIRE)-- Cybin Inc. (the “Company”) doing business as Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (“Helus Pharma”), a clinical stage pharmaceutical company committed to ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果